Australia TGA ARTG recordFungal infectious disease IVDs
Australia TGA ARTG Registered Device · R-Biopharm Pty Ltd · R-Biopharm AG · Class IIa · Started August 06, 2014
Good Name: R-Biopharm Pty Ltd - Fungal infectious disease IVDs
- Risk Class
- Class IIa
- Product Type
- IVD
- ARTG Category
- IVD
- Start Date
- August 06, 2014
- Effective Date
- August 06, 2014
- Name
- R-Biopharm AG
- Country
- Germany
- Address
- An der neuen Bergstrasse 17, Darmstadt, 64297
Intended to be used in testing to provide information about infection with or exposure to one or a number of yeast and/or other fungal infections
Access comprehensive regulatory information for Fungal infectious disease IVDs in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by R-Biopharm Pty Ltd, manufactured by R-Biopharm AG in Germany. The device registration started on August 06, 2014.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.